Getting The Deal Through logo
Getting The Deal Through


Judge requests time capsule of submissions to assess EMA Brexit lawsuit

Pharma - News – 02 October 2018

An English judge has asked lawyers for the European Medicines Agency and the Canary Wharf Group to make submissions that will help him “go back in time” to 2011, to better assess the predictability of Brexit at the time the agency signed its London lease.


Community round-up: O’Melveny poaches from Paul Hastings, Crowell recruits from Eversheds

Pharma - News – 02 October 2018

The past week has seen new lateral hires by life sciences teams at O’Melveny, Crowell & Moring and King & Spalding, as well as a US new general counsel at Bayer. 


EU court agrees with rejection of competition complaint against GSK despite error

Pharma - News – 02 October 2018

The EU General Court has found that the European Commission acted legally when it rejected a complaint alleging anticompetitive dual pricing in the pharmaceutical market, despite it misinterpreting a previous judgment on the enforcer’s 2001 decision.


Bayer and Novartis denied judicial review of Northern NHS groups’ Avastin policy

Pharma - News – 25 September 2018

The High Court in London has refused to grant drugmakers Bayer and Novartis’ request for a judicial review of a decision by 12 NHS clinical commissioning groups (CCGs) in the north of England to offer Roche’s Avastin as a preferred treatment option for a degenerative sight condition, rather than their more expensive alternatives.


DLA Piper recruits from Hogan Lovells and Vinson & Elkins in the US

Pharma - News – 25 September 2018

DLA Piper’s US life sciences group has hired two IP partners from Hogan Lovells in New York and a litigator from Vinson & Elkins in Texas.


Ropes & Gray advises Medtronic on Mazor Robotics acquisition

Pharma - News – 25 September 2018

Lawyers from Ropes & Gray have represented Dublin-based medical device company Medtronic in its US$1.64 billion acquisition of Israel’s Mazor Robotics.






Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn